Article
Rupert Barrett-Taylor, Gavin Wilde
{
"authors": [
"Gavin Wilde"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace"
],
"collections": [],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Endowment for International Peace",
"programAffiliation": "TIA",
"programs": [
"Technology and International Affairs"
],
"projects": [],
"regions": [
"Russia",
"Iran"
],
"topics": [
"Political Reform"
]
}
REQUIRED IMAGE
In The Media
In Russia’s Information War, a New Field of Study Gains Traction
Less than a year before Vladimir Putin unleashed the largest armed conflict on European soil since World War II, the Kremlin quietly expanded the Russian Security Council’s Science Council, an advisory body composed of nearly 150 prominent academics and government figures.
By Gavin Wilde
Published on Sep 14, 2022
About the Author
Gavin Wilde
Former Nonresident Fellow, Technology and International Affairs
Gavin Wilde was a nonresident fellow in the Technology and International Affairs Program at the Carnegie Endowment for International Peace. He applies his expertise on Russia and information warfare to examine the strategic challenges posed by cyber and information operations, propaganda, and emerging technologies.
- A Digitized, Efficient Model of War
- The Misguided Emphasis on U.S. Political Campaign HacksCommentary
Gavin Wilde
Recent Work
Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie India
- Managing Divergence: India’s BRICS Presidency in 2026Article
This piece argues that India’s central challenge is not managing a single flashpoint but resolving the underlying tension between expansion and institutional coherency of the BRICS grouping.
Vrinda Sahai
- How WHO’s “One Health” Program Can Help India Tackle MonkeypoxCommentary
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
- Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in IndiaPaper
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
- Combating Vaccine Hesitancy in IndiaCommentary
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
- How Should Countries Study Viruses Safely?Commentary
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma
